
Levi & Korsinsky Urges Shareholders: Meet the Lead Plaintiff Deadline in This Ongoing Business Case
Understanding the Pacira BioSciences, Inc. Lawsuit: What It Means for Investors and the World On February 21, 2025, ACCESS Newswire announced that investors who suffered losses due to misrepresentations by Pacira BioSciences, Inc. (NASDAQ: PCRX) may be able to recover their losses through a securities class action lawsuit. The lawsuit alleges that Pacira BioSciences and…